Skip to main content
Caplight Logo









TrianecT

TrianecT

Private
UtrechtHealthcare & Life Scienceshttps://trianect.com/

Last Round

VC Round

Jul 8, 2025

Total Funding Raised

$270,000

Company Overview

TrianecT is a medical technology company that develops StrokePointer™, a portable device that uses EEG technology and artificial intelligence to enable ambulance personnel to diagnose severe strokes and triage patients to the appropriate hospital.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

stroke triagemedical deviceEEGlarge vessel occlusionLVOpre-hospital diagnosticsmedical AIpoint-of-care diagnosticsstroke detectionmedtechEMS technologyhealth IoTportable diagnostic deviceclinical decision supportambulance equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TrianecT Comparables

Compare TrianecT with similar companies based on industry and business-model similarity.

TrianecT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MindRhythm
91%
Forest Devices
89%
SPKL
81%

TrianecT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 8, 2025
GrantDec 12, 2023

TrianecT Investors

Notable investors and investment history

TrianecT investors
InvestorRounds
Netherlands Organization for Scientific ResearchGrant
CbusineZVC Round
XO VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 207% MoM, from 483 to 1.5K.

  • Jul 8, 2025

    $1.58M round led by XO Ventures

TrianecT Filings

Explore SEC and related filing metadata, where available.

TrianecT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TrianecT's valuation, stock price, and market status.

Is TrianecT a public or private company?

TrianecT is a private company.

What is the current stock price of TrianecT?

TrianecT is a private company, so its shares have no public market price. Caplight tracks TrianecT's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TrianecT worth (valuation)?

Valuation information for TrianecT is not publicly available.

Can I buy TrianecT stock?

TrianecT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TrianecT's last funding round?

TrianecT's most recent funding round was VC Round on July 8, 2025.

Who are the main investors in TrianecT?

Key investors in TrianecT include XO Ventures.

Will TrianecT IPO soon?

No public IPO plans have been announced for TrianecT.

How can I track TrianecT secondary market activity?

Caplight tracks bids, offers, and trades in TrianecT's shares on secondary markets.

Firmographic Details

HeadquartersUtrecht
Employee Range9
Year Founded2022
Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?